860508 | C8 Ceramide (d18:1/8:0)
N-octanoyl-D-erythro-sphingosine
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C8 Ceramide (d18:1/8:0)
N-octanoyl-D-erythro-sphingosine
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by BiozO'Brien KA, Atkinson RA, Richardson L, Koulman A, Murray AJ, Harridge SDR, Martin DS, Levett DZH, Mitchell K, Mythen MG, Montgomery HE, Grocott MPW, Griffin JL, Edwards LM. Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp. Sci Rep. 2019 Feb 19;9(1):2297. doi: 10.1038/s41598-019-38832-z.
PubMed ID: 30783167Huiqing Lv , Zhongmin Zhang, Xiaoyu Wu , Yaoxia Wang, Chenglin Li, Weihong Gong, Liang Gui , Xin Wang Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent. [PubMed]
- Certificate of Analysis (Lot No. 860508P-5MG-A-015 and 5964PHA015)
- Certificate of Analysis (Lot No. 860508P-5MG-B-015 and 5964PHB015)
- Certificate of Analysis (Lot No. 860508P-5MG-C-015 and 5964PHC015)
- Certificate of Analysis (Lot No. 860508P-5MG-D-015 and 5964PHD015)
- Certificate of Analysis (Lot No. 860508P-5MG-E-015 and 5964PHE015)
- Certificate of Analysis (Lot No. 860508P-5MG-F-015 and 5964PHF015)
- Certificate of Analysis (Lot No. 860508P-5MG-G-015 and 5964PHG015)
- Certificate of Analysis (Lot No. 860508P-5MG-H-015 and 5964PHH015)
